Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases
Amount Raised
$80 Million
Round Type
Series A
MorrisvilleBiotechnologyresearchDescription
Kriya Therapeutics announced today that it has raised $80.5 million in a Series A financing to fund the development of transformative gene therapies for highly prevalent serious diseases. Kriya was formed in the fourth quarter of 2019 and has an industry-leading gene therapy team that includes former senior leadership from Spark Therapeutics, AveXis, Sangamo Therapeutics, and other gene therapy companies. Kriya's pipeline today includes multiple AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, and other indications. The company is located in the Bay Area, California and Research Triangle Park, North Carolina, and is building a platform infrastructure in partnership with leading academic institutions and industry pioneers.
Quick answer
Kriya Therapeutics raised $80 Million in a Series A round, dated May 12, 2020. Kriya Therapeutics is based in Morrisville, North Carolina, United States.
- How much did Kriya Therapeutics raise?
- Kriya Therapeutics raised $80 Million in a Series A round on May 12, 2020.
- What does Kriya Therapeutics do?
- Kriya is a biopharmaceutical company on a mission to revolutionize medicine by developing gene therapies that aim to eliminate human suffering and free people from the burden of chronic disease.
- Where is Kriya Therapeutics based and how big is it?
- Kriya Therapeutics is based in Morrisville, North Carolina, United States. Fundz records about 190 employees.
- Who are the decision-makers at Kriya Therapeutics?
- Fundz holds 2 contacts at Kriya Therapeutics, including the Chief Regulatory Officer at Kriya Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Kriya Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Scientific Industries raised $6.1M on June 25, 2020.
- BioLineRx Ltd raised $9M on June 10, 2020.
- BioLineRx Ltd raised $4.4M (Pre-Seed) on June 10, 2020.
- Genomenon, Inc. raised $2.9M (Seed) on May 21, 2020.
- Grail raised $390M (Series D) on May 6, 2020.
- Legend Biotech raised $150M on April 7, 2020.
Who to call at Kriya Therapeutics, and when
A new round usually means Kriya Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kriya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kriya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kriya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kriya Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKriya Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.